NYSE: MPT

Medical Properties Trust Inc. (MPT)

Medical Properties Trust Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker MPT. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
MPT
Exchange
NYSE
SEC CIK
1287865
Official filings
SEC EDGAR

Research MPT

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Medical Properties Trust Inc.'s stock ticker?

Medical Properties Trust Inc. trades under the ticker symbol MPT on NYSE. Its SEC Central Index Key (CIK) is 1287865.

Where can I read Medical Properties Trust Inc.'s SEC filings?

The MPT SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Medical Properties Trust Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze MPT's financial statements?

The MPT Financials page shows Medical Properties Trust Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does MPT compare with its peers and the market?

The MPT Peer Comparison page lines Medical Properties Trust Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.